Parents' experience of a child with a large birthmark
Part of Genetic & congenital, Mental health, Skin clinical trials.
This study explores how parents feel and cope when their child has a large congenital melanocytic nevus, a type of birthmark. You would take part in a one-on-one interview to share your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are the parent of a child under 18 who has a large congenital melanocytic nevus.
- You can speak and understand French.
- You are willing to talk in a recorded interview.
- You are not under legal guardianship or curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain birthmarks (nevi) change over time and might turn into melanoma. By studying tissue samples, researchers hope to better understand this process.
This early study tests whether a medicine called SADBE can help treat congenital (from birth) melanocytic nevi—large birthmark moles—before planned non-urgent removal. The goal is to see if SADBE is safe and helpful for these large moles.
This trial uses a precision medicine approach for people with melanoma. It studies how volatile organic compounds (substances your body releases) might help guide treatment for stage II, III, or IV melanoma.
This study looks at how removing a large birthmark mole (a congenital melanocytic nevus) affects children’s quality of life and how much they feel stigmatized. It may help doctors understand what to expect and how to support kids before and after surgery.
This study asks parents to share their personal experience after finishing parent-child psychotherapy for a young child. Researchers hope to understand what parents feel helped (or didn’t) so future therapy can be improved.
This study follows babies and toddlers with medium to large birthmarks to understand how they change over time and plan the best care. It will help doctors give better advice to families.
Hear when a new Congenital Melanocytic Nevus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.